Literature DB >> 15337376

Overexpression of NPY and Y2 receptors in epileptic brain tissue: an endogenous neuroprotective mechanism in temporal lobe epilepsy?

Annamaria Vezzani1, Günther Sperk.   

Abstract

Recurrent epileptic seizures in the rat enhance the expression of neuropeptide Y (NPY) and its mRNA in various brain areas including the hippocampus, cerebral cortex and the amygdala. In the hippocampus, the most prominent expression of NPY is observed in mossy fibers and in GABAergic interneurons. At the same time, expression of Y2 receptors is also increased whereas Y1 receptors are reduced. Similar changes in Y1 and Y2 receptors were observed in the hippocampus of patients with temporal lobe epilepsy (TLE). In contrast to the rat, NPY expression is not enhanced in mossy fibers in TLE. In the same tissue, surviving NPY interneurons show marked axonal sprouting into areas innervated by mossy fibers (dentate hilus, stratum lucidum, inner molecular layer of the dentate gyrus). Stimulation of presynaptic Y2 receptors inhibits glutamate release, and exert an anticonvulsant action in experimental models. Y1 receptors mediate a weak excitatory component of NPY action. These findings suggest that changes in the NPY system induced by seizures represent an endogenous adaptive mechanism aimed at counteracting hyperexcitability underlying epileptic activity. This concept is strongly supported by evidence that genetically modified rats overexpressing the NPY gene are less susceptible to seizures while deletion of NPY or Y2 receptor genes results in increased susceptibility to seizures.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15337376     DOI: 10.1016/j.npep.2004.05.004

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  48 in total

Review 1.  Gene therapy for epilepsy.

Authors:  David W McCandless; Jeffrey W McCandless
Journal:  Metab Brain Dis       Date:  2010-09-23       Impact factor: 3.584

Review 2.  NPY and stress 30 years later: the peripheral view.

Authors:  Dalay Hirsch; Zofia Zukowska
Journal:  Cell Mol Neurobiol       Date:  2012-01-24       Impact factor: 5.046

Review 3.  Current prospects and challenges for epilepsy gene therapy.

Authors:  Marc S Weinberg; Thomas J McCown
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

Review 4.  Genetics of drug resistance in epilepsy.

Authors:  Sanjay M Sisodiya
Journal:  Curr Neurol Neurosci Rep       Date:  2005-07       Impact factor: 5.081

Review 5.  Neuropeptide Y in the recurrent mossy fiber pathway.

Authors:  J Victor Nadler; Bin Tu; Olga Timofeeva; Yiqun Jiao; Herbert Herzog
Journal:  Peptides       Date:  2007-01-03       Impact factor: 3.750

Review 6.  Neuropeptide Y Y2 receptor in health and disease.

Authors:  S L Parker; A Balasubramaniam
Journal:  Br J Pharmacol       Date:  2007-09-10       Impact factor: 8.739

7.  Cell and gene therapies for refractory epilepsy.

Authors:  Detlev Boison
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

8.  NPY signaling through Y1 receptors modulates thalamic oscillations.

Authors:  Julia Brill; Gunnar Kwakye; John R Huguenard
Journal:  Peptides       Date:  2006-12-29       Impact factor: 3.750

Review 9.  Neuronal plasticity in animal models and the epileptic human hippocampus.

Authors:  Gunther Sperk; Meinrad Drexel; Susanne Pirker
Journal:  Epilepsia       Date:  2009-12       Impact factor: 5.864

10.  Bilateral reorganization of the dentate gyrus in hippocampal sclerosis: a postmortem study.

Authors:  M Thom; L Martinian; C Catarino; M Yogarajah; M J Koepp; L Caboclo; S M Sisodiya
Journal:  Neurology       Date:  2009-08-26       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.